We generate over 4,000 proprietary deal leads per year
Exclusive customized deals for our clients are not in this list. Please contact us with the Deal ID if you are interested in any specific opportunity
Date  |
Deal ID |
Sector |
Deal Type |
Deal Currency |
Revenue |
Deal Size |
| 29/05/2018 |
14521 |
Business Service / TMT / Industrials |
Private Placement |
RMB / USD |
N/A |
RMB 400 m |
- A private company focusing on big data platform and solutions
- Planning to raise fund of at least RMB 300m to RMB 500m in late 2018 or early 2019
- The core product being a certain big data platform
Become Client
Learn More
| 28/05/2018 |
14517 |
Business Service / Consumer |
M&A |
RMB / USD |
RMB 60 m |
N/A |
4517, founded in 2009, is a private operator of kindergartens and provider of preschool education curriculum equipment. The company is now considering to be sold. The Companys 2017 revenue was more than 60 million, it is not yet profitable. 4517 is operating 10 wholly-owned kindergardens and 20 franchised kindergardens.
Become Client
Learn More
| 22/05/2018 |
14471 |
Industrials |
Private Placement / M&A |
RMB / USD |
RMB 35 m |
RMB 80 m |
4471 is a private company that develops and produces biodegradable materials; it plans to launch a private placement raising RMB 80 million. The revenue in 2017 reached RMB 10 million to RMB 20 million, and is not yet profitable. It is expected to break even with revenues of RMB 30 to RMB 40 million in 2018.
Become Client
Learn More
| 17/05/2018 |
14452 |
Business Service / Consumer |
Private Placement |
RMB |
RMB 3500 m |
RMB 80 m |
4421 is a private company based in Shanghai offering large package (3-30KG) delivery services. It plans to launch a private placement raising RMB 70 to 100 million between August and September 2018. The company prefers funding from RMB funds. The proceeds will mainly be used for talent recruitment and IT and R&D investment. An exclusive financial advisor is currently being hired.The revenue of 4452 in 2017 reached RMB 2.6 billion and the platform trading volume was RMB 7.0 billion, the company is currently loss-making; revenue for 2018 is
Become Client
Learn More
| 10/05/2018 |
14420 |
Business Service |
Private Placement / M&A |
RMB / USD |
RMB 20 m |
RMB 15 m |
4420 is a private enterprise providing IoT products and services for the breeding industry. The company is now planning a private placement raising RMB 15 million, with an overall valuation of RMB 100 million. Both renminbi and dollar funds are acceptable. The revenue of the company was around RMB 10 million in 2017, and revenue is expected to be RMB 20 million in 2018, with a projected net profit RMB 5 million. The annual net profit was more than RMB 3 million before 2015.
Become Client
Learn More
| 09/05/2018 |
14399 |
Consumer |
M&A |
RMB / USD |
RMB 300 m |
N/A |
4399, a restaurant chain brand of Cantonese style soup and cuisine, is willing to talk to strategic investors and is considering sale of the controlling stake. Its revenue in 2015 reached RMB 300 million and the net profit RMB10 million. It operates over 25 stores in 3 cities.
Become Client
Learn More
| 07/05/2018 |
14393 |
Business Service |
Private Placement / M&A |
RMB / USD |
RMB 1000 m |
RMB 90 m |
4393, a private company providing Less-than-Truck-Load and urban express delivery, plans to launch a private placement of RMB 80 million to RMB 100 million. In 2017, the revenue was RMB 850 million and net profit RMB 2 million; and the projected revenue in 2018 reaches RMB 1 billion and net profit RMB 7 million.
Become Client
Learn More
| 25/04/2018 |
14345 |
Healthcare / TMT |
Private Placement |
RMB |
RMB 20 m |
RMB 30 m |
4345, located in Guangzhou, is a third-party O2O mobile medical service operator. It is currently conducting a 30 million RMB financing, selling 10% stake, valuing the company at RMB 300 million post-investment. The Company is interested by investors who can provide strategic resources. In January 2017, it received aRMB 20 million investment valuing the at 200 million yuan post-investment. 4345 generated RMB 11 million in revenue2018 revenue is expected to reach RMB 20 million yuan. By the end of 2017, its users number reached 4.3 million and has a MAU of 250,000 users.
Become Client
Learn More
| 19/04/2018 |
14317 |
Consumer |
Private Placement / M&A |
RMB / USD |
N/A |
N/A |
4371 is a Chengdu based hotpot restaurant chains is planning to bring in external capital to drive business development and innovation. Company’s system sales exceeded RMB 1.0 billion in 2017. Its net revenue is around RMB 200 million. It operates 10 wholly-owned stores and has 70 franchised stores.
Become Client
Learn More
| 18/04/2018 |
14304 |
Consumer |
Private Placement / M&A |
RMB / USD |
N/A |
N/A |
A Chengdu based hotpot restaurant chain, is looking for minority investment. The company is also considering selling controlling stake. In 2017, the sales of wholly-owned outlet reached more than RMB 100 million. The average daily turnover of a single wholly-owned outlet is RMB 60 thousand. The Company also has close to 60 franchised stores.
Become Client
Learn More
| 18/04/2018 |
14306 |
Consumer |
Private Placement / M&A |
RMB / USD |
RMB 80 m |
N/A |
4306 is a Chengdu based restaurant chain operating frog and fish hotpot is planning to raise capital to expand its store network. The company is also considering the sell the controlling stake. The revenue of the company in 2017 was less than RMB 80 million and was profitable. The product targets at 18 to 35 years-old people, and the average ticket is RMB70 to RMB80.
Become Client
Learn More
| 18/04/2018 |
14308 |
Industrials |
Private Placement |
RMB / USD |
RMB 200 m |
N/A |
4308, a private company that develops and produces starch-based biodegradable plastics, is considering selling its controlling stake. The revenue in 2015 revenue was RMB 200 million and the net profit over RMB 10 million; the net profit in 2016 was RMB 200 million.
Become Client
Learn More
| 11/04/2018 |
14280 |
Healthcare |
Private Placement / M&A |
RMB / USD |
RMB 68 m |
RMB 20 m |
A private enterprise that develops and produces breathing and anesthetic machines, is raising RMB 20 million for minority investment with a pre-investment valuation of RMB 180 million. It is also considering selling controlling stake. The revenue in 2017 was RMB 36.5 million and the company broke even; the revenue is expected to reach RMB 65 million to RMB 70 million in 2018, with a net profit of RMB 10 million.
Become Client
Learn More
| 10/04/2018 |
14263 |
Consumer |
Private Placement / M&A |
RMB / USD |
RMB 160 m |
N/A |
A private agricultural group that develops and sells pomegranate products, is willing to accept minority investment or sell controlling stake. The major product of the company is pomegranate. In 2017, revenue of the company was RMB 144 million; the net profit was RMB 31.0 million. Revenue is estimated to be RMB 160 million in 2018 and the net profit is expected to be RMB 34 million.
Become Client
Learn More
| 09/04/2018 |
14257 |
Healthcare |
M&A |
RMB / USD |
RMB 200 m |
N/A |
A private enterprise engaged in production and processing of traditional Chinese medicine, operation of Chinese medicine chains and management of health services is considering selling controlling stake of its pharmacy chain. The revenue of the pharmacy chain was about RMB 200 million and net profit RMB 14 million in 2017.
Become Client
Learn More
| 07/04/2018 |
14253 |
Healthcare |
M&A |
RMB / USD |
N/A |
N/A |
A NEEQ listed company engaged in development and production of Class-III interventional medical devices, such as cardiovascular stents is considering selling controlling stake, but does not consider follow-on offering in 2018 so far. The main products include coronary stenting system and balloon dilatation catheter. The net profit of the company in 2017 was over RMB 20 million.
Become Client
Learn More
| 02/04/2018 |
14238 |
Healthcare |
M&A |
RMB |
N/A |
N/A |
A Jiangsu based private company engaged in the operation of ophthalmic hospitals and is currently talking to a large domestic ophthalmic group for equity partnership. The Company considers to sell 51% of its shares. The ophthalmic group is ready for due diligence but the Company welcomes other potential investors/buyers. It reported a net profit of nearly RMB 10 million in 2015.
Become Client
Learn More
| 28/03/2018 |
14223 |
Healthcare |
M&A |
RMB / USD |
RMB 70 m |
RMB 175 m |
A private company engaged in the development and production of hearing aids, is considering talking to investors for equity partnership. The company prefers to sell controlling stake. The overall valuation of the company is about RMB 150 million to RMB 200 million. The company’s major products are hearing aids for the elders. In 2017, revenue was RMB 70 million, with a net profit margin of nearly 20%. Previously, the growth rate of the company was 30% per year.
Become Client
Learn More
| 28/03/2018 |
14224 |
Consumer / Industrials |
M&A |
RMB / USD |
RMB 240 m |
RMB 200 m |
A private enterprise focusing on mid to high-end bedding products, is considering selling controlling stake. Management Buyout (MBO) is also considered with the right investors. The overall valuation is around RMB 200 million. The companys main products are intelligent pillow and bedding. In 2017, the revenue was RMB 170 million, the net profit about RMB 12 million. Sales in 2018 is expected to range from RMB 230 million to RMB 250 million, with a net profit of RMB 20 million.
Become Client
Learn More
| 28/03/2018 |
14228 |
Consumer / Industrials |
M&A |
RMB / USD |
RMB 200 m |
N/A |
A Hangzhou-based private enterprise, is now willing to negotiate with investors to sell controlling stake; minority equity could also be discussed. Major products include maternal and child food, skin care products, and daily detergent. In 2017, the revenue of the company was over RMB 100 million and net profit several million RMB; the revenue is expected to reach RMB 200 million in 2018, with net profit RMB 30 million.
Become Client
Learn More
